Lars Fruergaard Jørgensen CEO of Novo Nordisk 2025
Lars Fruergaard Jørgensen, a Danish business executive, has been at the helm of Novo Nordisk, a global pharmaceutical giant renowned for its leadership in diabetes and obesity care, since January 2017. His tenure has been marked by extraordinary growth, significant strategic pivots, and, more recently, the complexities of intense market competition and a leadership transition. […]
Lars Fruergaard Jørgensen CEO of Novo Nordisk 2025 Read More »










